Same old, same old...
My favourite line:
"Poseidon has a proven track record in discovering new ore bodies, securing existing operations and applying a novel and inventive approach to unlocking capital" (p.1, emphasis added).
Jaundiced humour aside, I was expecting the addition of the extra (third) cash raising during the quarter to be an attempt to rebuild the closing cash on hand balance to a little over $2M, but it was not the case. Basically, we needed that additional ~$500k to meet our (now) increased cash burn.
Bottom line: It looks like 3 x 20M-share CRs per quarter is the 'new normal' for the foreseeable future. And on that basis, we can expect to be diluted by another ~25% (through CRs alone) by this time next year.
Awesome!
- Forums
- ASX - By Stock
- POS
- Ann: Quarterly Report to 30 September 2017
Ann: Quarterly Report to 30 September 2017, page-7
-
- There are more pages in this discussion • 67 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add POS (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $21.01M |
Open | High | Low | Value | Volume |
0.5¢ | 0.5¢ | 0.5¢ | $9.053K | 1.810M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
67 | 66094422 | 0.4¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.5¢ | 208484 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
67 | 66094422 | 0.004 |
71 | 44988587 | 0.003 |
18 | 42977935 | 0.002 |
13 | 33178647 | 0.001 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.005 | 208484 | 1 |
0.006 | 36031433 | 36 |
0.007 | 5802781 | 18 |
0.008 | 3065134 | 6 |
0.009 | 98928 | 2 |
Last trade - 11.59am 13/11/2024 (20 minute delay) ? |
Featured News
POS (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online